** Shares of New Zealand-based medical services provider
Volpara Health Technologies VHT.AX rise as much as 14% to
A$0.735, their highest since June 2
** The ASX-listed co updates strategy and sees operational
cost reductions of about NZ$3 mln ($1.88 mln) in H2 FY23 and
NZ$7-$8 mln in FY 24 urn:newsml:reuters.com:*:nASX5lGfNr
** Co expects revenue from customers in the range of NZ$31.5
mln to NZ$33 mln in FY23
** Says co focusing on sales growth among large commercial
opportunities in U.S. and Australia
** More than 409,000 shares change hands, vs the 30-day
average volume of 454,048 shares
** Stock posts its biggest intraday pct gain since July 4
** Stock down 38% this year, as of last close
($1 = 1.5954 New Zealand dollars)
(Reporting by Rishav Chatterjee in Bengaluru)